- Home
- ABAT vs COYA Comparison
ABAT vs COYA Comparison
Compare ABAT & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABAT
- COYA
- Stock Information
- Founded
- ABAT 2011
- COYA 2020
- Country
- ABAT United States
- COYA United States
- Employees
- ABAT N/A
- COYA N/A
- Industry
- ABAT Metal Mining
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- ABAT Basic Materials
- COYA Health Care
- Exchange
- ABAT Nasdaq
- COYA Nasdaq
- Market Cap
- ABAT 87.2M
- COYA 103.2M
- IPO Year
- ABAT N/A
- COYA 2022
- Fundamental
- Price
- ABAT $1.40
- COYA $6.05
- Analyst Decision
- ABAT
- COYA Strong Buy
- Analyst Count
- ABAT 0
- COYA 4
- Target Price
- ABAT N/A
- COYA $17.00
- AVG Volume (30 Days)
- ABAT 2.0M
- COYA 68.3K
- Earning Date
- ABAT 05-19-2025
- COYA 05-16-2025
- Dividend Yield
- ABAT N/A
- COYA N/A
- EPS Growth
- ABAT N/A
- COYA N/A
- EPS
- ABAT N/A
- COYA N/A
- Revenue
- ABAT $877,900.00
- COYA $3,554,061.00
- Revenue This Year
- ABAT $31,748.62
- COYA $94.45
- Revenue Next Year
- ABAT N/A
- COYA N/A
- P/E Ratio
- ABAT N/A
- COYA N/A
- Revenue Growth
- ABAT N/A
- COYA N/A
- 52 Week Low
- ABAT $0.73
- COYA $4.65
- 52 Week High
- ABAT $4.11
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- ABAT 57.02
- COYA 49.30
- Support Level
- ABAT $1.30
- COYA $5.77
- Resistance Level
- ABAT $1.46
- COYA $6.59
- Average True Range (ATR)
- ABAT 0.16
- COYA 0.54
- MACD
- ABAT 0.01
- COYA 0.01
- Stochastic Oscillator
- ABAT 47.14
- COYA 24.81
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.